Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ZyVersa Therapeutics, Inc. | Director | Stock Options | 572 | May 24, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ZVSA | ZyVersa Therapeutics, Inc. | May 24, 2023 | 1 | $0 | 4 | Jul 18, 2024 | Director |
ZVSA | ZyVersa Therapeutics, Inc. | Dec 12, 2022 | 5 | $0 | 4 | Dec 14, 2022 | Chief Commercial Officer |
ZVSA | ZyVersa Therapeutics, Inc. | Dec 12, 2022 | 0 | $0 | 3 | Dec 13, 2022 | Chief Commercial Officer |